DJ Biogen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.15% to $187.88 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.41% to 7,108.40 and Dow Jones Industrial Average falling 0.36% to 49,310.32.
The stock's fall snapped a four-day winning streak.
Biogen Inc. closed 7.18% below its 52-week high of $202.41, which the company reached on February 6th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 2.01% to $230.65, Pfizer Inc. $(PFE)$ fell 0.49% to $26.67, and AbbVie Inc. $(ABBV)$ rose 0.22% to $200.95.
Trading volume (816,060) remained 327,238 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 23, 2026 16:59 ET (20:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments